Devika Proteins Ltd (DHARTI) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Devika Proteins Ltd on NSE and BSE, with an AI summary of each filing.
Outcome of 4th Implementation and Monitoring Committee meeting has been attached herewith.
Others (Uncategorized) · 15 Oct 2026, 11:54 pm
Dharti Proteins Concludes 4th Implementation and Monitoring Committee Meeting Dharti Proteins Limited announced that the 4th meeting of its Implementation and Monitoring Committee was held on 15th Oct'26 via video conferencing from 05:00 PM to 05:37 PM, in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was submitted by CS & IP Amrish Gandhi, the Erstwhile Resolution Professional of the company.
The notice of Extra Ordinary General Meeting of the company to be held on November 06, 2026 has been attached herewith.
Extra Ordinary General Meeting · 14 Oct 2026, 1:29 am
Dharti Proteins Convenes EOGM to Approve 1:1 Bonus Issue for Public Shareholders Dharti Proteins has scheduled an EOGM on 6th Nov'26 to approve a 1:1 bonus issue exclusively for public shareholders to comply with Minimum Public Shareholding norms. Promoters will forgo their entitlement, expanding total outstanding equity from 5,00,000 to 5,75,000 shares via capitalization of Rs 7.50 lakh from free reserves. Consequently, paid-up capital will increase to Rs 57.50 lakh, raising public shareholding from 5% to 26.08%. The remote e-voting window runs from 3rd Nov'26 to 5th Nov'26, with the cut-off date set for 28th Oct'26.
The Board has recommended issuance of Bonus shares to public shareholders (except promoter and promoter group) in the ratio of 1:1 i.e. 1 equity share of Rs. 10/- each for every 1 equity ....
Bonus Issue · 14 Oct 2026, 1:26 am
Dharti Proteins Reports Q2 Results and Recommends 1:1 Public Bonus Issue Dharti Proteins reported revenue from operations of Rs. 285.13 lakhs and net profit of Rs. 337.24 lakhs for the quarter ended 30th Sep'26, driven by a Rs. 314.50 lakhs loan waiver from its Managing Director recognized as other income. The board recommended a 1:1 bonus issue of 75,000 equity shares exclusively to public shareholders to comply with SEBI minimum public shareholding norms, capitalizing Rs. 7.50 lakhs from reserves. Additionally, the company approved appointing Bigshare Services as RTA and scheduled an EGM on 6th Nov'26.
The Company has appointed M/s. J.M. Patel & Bros. as Tax Auditor of the Company for the financial year 2026-27 in the meeting of Board of directors held on October 13, 2026.
Change in Management · 14 Oct 2026, 1:23 am
Dharti Proteins Reports Q2 Results and Recommends 1:1 Bonus Issue Dharti Proteins reported Q2 results for the period ended 30th Sep'26, with revenue from operations reaching Rs. 285.13 lakhs and net profit standing at Rs. 337.24 lakhs (EPS of Rs. 67.45), boosted by Rs. 314.50 lakhs in other income from a loan waiver by its Managing Director. The Board recommended a 1:1 bonus issue exclusively for public shareholders to meet minimum public shareholding norms, approved changing its RTA to Bigshare Services, and appointed M/s J M Patel & Bros as Tax Auditor for FY'27.
The Audited Standalone Financial Results for the quarter and half year ended September 30, 2026 along with Interim Audit Report has been attached herewith.
Financial Result · 14 Oct 2026, 1:20 am
Dharti Proteins Reports Q2 FY27 Results and Proposes 1:1 Public Bonus Issue For the quarter ended 30th Sep'26, Dharti Proteins reported revenue from operations of Rs. 285.13 lakhs and net profit of Rs. 337.24 lakhs (EPS Rs. 67.45), boosted by Rs. 314.50 lakhs in other income from an unsecured loan waiver by its Managing Director. For H1 FY27, revenue reached Rs. 285.13 lakhs with net profit of Rs. 322.96 lakhs. The board approved a 1:1 bonus issue exclusively for public shareholders to meet minimum public shareholding norms and appointed Bigshare Services as its new RTA.
Due to typographical error, the revised outcome of meeting of Board of Directors held on Tuesday, 13th October, 2026, has been attached herewith.
Outcome · 14 Oct 2026, 1:12 am
Dharti Proteins Posts Q2 Profit, Proposes 1:1 Public Bonus Issue Dharti Proteins reported revenue from operations of Rs. 285.13 lakhs and net profit of Rs. 337.24 lakhs for Q2 ended 30th Sep'26, compared to a net loss of Rs. 0.42 lakhs in Q2 ended 30th Sep'25, boosted by Rs. 314.50 lakhs in other income from a Managing Director loan waiver. The Board recommended a 1:1 bonus share issue exclusively for public shareholders to meet minimum public shareholding norms, increasing paid-up capital from Rs. 50.00 lakhs to Rs. 57.50 lakhs.
The Outcome of meeting of board of directors held today i.e. Tuesday, 13th day of October, 2026 has been attached herewith.
Outcome · 14 Oct 2026, 1:01 am
Devika Proteins Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 285 ■ EBITDA: 127 (Loss to Profit YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 44.5 ■ PAT: 337 (Loss to Profit YoY | Loss to Profit QoQ) ■ EPS (INR): 67.5 (Loss to Profit QoQ)
Dharti Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/10/2026 ,inter alia, to consider and approve 1. The Audited Standalone Financial ....
Intimation · 13 Oct 2026, 5:30 am
Dharti Proteins Board to Consider Q2 Results and Bonus Share Issue Dharti Proteins Limited announced that its Board of Directors will meet on 13th Oct'26. The board will consider and approve the audited standalone financial results along with the interim audit report for the quarter and half-year ended 30th Sep'26. Additionally, the board will evaluate a proposal to issue bonus shares specifically to public shareholders to comply with mandated Minimum Public Shareholding requirements under SEBI regulations and the Securities Contracts (Regulation) Rules.
The Object Clause has been altered pursuant to approval by Shareholders in 32nd Annual General Meeting held on Monday, 28th September, 2026 and Registrar of Companies vide its letter dated ....
Others (Uncategorized) · 08 Oct 2026, 9:51 pm
Intimation of Trading Approval received from BSE Limited for 5,00,000 equity shares of Rs. 10/- each has been attached herewith.
Others (Uncategorized) · 07 Oct 2026, 3:57 pm
BSE Approves Trading of Dharti Proteins Post-Resolution Restructured Equity Shares BSE has granted trading approval for 5,00,000 equity shares (face value Rs. 10 each) of Dharti Proteins Ltd, effective 8th Oct'26 in the XT group under Trade-to-Trade segment. Pursuant to the NCLT-approved resolution plan dated 18th Nov'25, paid-up capital was restructured from Rs. 10.28 cr (1.03 cr shares) to Rs. 50.00 lakh (5,00,000 shares). The allotment comprises 4,25,000 shares to the Successful Resolution Applicant and promoters, 50,000 shares to Secured Financial Creditors, and 25,000 shares (5% stake) to existing public shareholders on a proportionate basis.
The shareholders in the Annual General Meeting held on Monday, 28th September, 2026 adopted new set of Memorandum of Association (MOA) and Articles of Association (AOA) in substitution ....
Annual General Meeting · 30 Sept 2026, 11:34 pm
The Scrutinizer Report of 32nd Annual General Meeting (AGM) of the Company for the Financial Year 2025-26 held on Monday, 28th September, 2026 has been attached herewith.
Annual General Meeting · 29 Sept 2026, 11:01 pm
The Disclosure of the agreement entered between company and director in lieu of borrowing of the amount, as mentioned, dated September 28, 2026 has been attached herewith.
Others (Uncategorized) · 28 Sept 2026, 11:17 pm
Dharti Proteins Secures Up to Rs 100 Crore Convertible Loan From Promoter Dharti Proteins entered into a loan agreement on 28th Sep'26 to borrow an unsecured, interest-free loan of up to Rs 100 crore from Promoter and MD Jatinbhai Ramanbhai Patel, who holds a 5.00% equity stake. The loan, disbursed in tranches as required, is convertible into equity shares at a later date, subject to shareholder approval. The related-party transaction was approved by the board on 1st Sep'26 and subsequently by shareholders in the AGM held on 28th Sep'26.
The outcome of 32nd Annual General Meeting of the Company held on Monday, September 28, 2026, has been attached herewith.
Annual General Meeting · 28 Sept 2026, 11:04 pm
The Annual Report for the financial year 2025-26 has been attached herewith.
Others (Uncategorized) · 28 Sept 2026, 5:48 pm
The addendum to the notice of 32nd Annual General Meeting of the Company to be held on Monday, September 28, 2026 has been attached herewith.
Annual General Meeting · 10 Sept 2026, 4:17 pm
The Addendum to notice of 32nd Annual General Meeting of the Company to be held on Monday, September 28, 2026 is attached herewith.
Annual General Meeting · 10 Sept 2026, 12:02 am
The Newspaper Publication of Notice calling Annual General Meeting of the Company is attached herewith.
Annual General Meeting · 08 Sept 2026, 4:35 pm
The shareholders are hereby informed that the Annual General Meeting for the financial year 2025-26 is scheduled to be held on Monday, September 28, 2026. The detailed notice has been attached ....
Annual General Meeting · 03 Sept 2026, 10:52 pm
The Annual Report of the Company for the financial year 2025-26 has been attached herewith.
Others (Uncategorized) · 03 Sept 2026, 10:50 pm
The Board of Directors in their meeting held on Tuesday, September 01, 2026, took note of resignation of M/s. PSG & Associates as internal auditor of the company and pursuantly approved ....
Change in Management · 01 Sept 2026, 10:37 pm
Dharti Proteins Board Approves Auditor Change and Higher Borrowing Limits Dharti Proteins' board, in its meeting on 01st Sep'26, noted the resignation of internal auditor M/s. PSG & Associates and approved appointing M/s. Mikil Vora & Associates for a five-year term from FY27 to FY31. The board also approved increasing the company's borrowing limit to Rs. 5,000 crores to meet working capital and capex needs. Additionally, it approved increasing the limit for investments, loans, and guarantees to Rs. 5,000 crores. These proposals, along with altering the company's MoA and AoA, require shareholder approval.
The outcome of meeting of Board of Directors held on Tuesday, September 01, 2026 to consider inter alia: 1. Resignation of M/s. PSG & Associates; 2. Appointment of M/s. Mikil Vora & Associates; ....
Others (Uncategorized) · 01 Sept 2026, 10:33 pm
The Un-audited Financial Results for the quarter ended June 30, 2026, as approved by Board of Directors, have been attached herewith. The same are been re-uploaded due to typographical ....
Financial Result · 15 Jul 2026, 10:23 pm
Dharti Proteins Reports Q1 FY27 Results with Widened Net Loss Dharti Proteins reported Q1 FY27 results ending 30 Jun'26, posting a net loss of Rs. 14.28 lakhs, a significant increase from a loss of Rs. 4.60 lakhs YoY. Total revenue declined 97.4% YoY to Rs. 0.06 lakhs from Rs. 2.29 lakhs. Total expenses rose 108% YoY to Rs. 14.34 lakhs. The loss per share (EPS) widened to Rs. (2.86) from Rs. (0.04) in the prior year's quarter. The company received an unmodified limited review report from its auditors for the period.
The Un-audited Standalone Financial Results for the quarter ended June 30, 2026, as approved by Board of Directors in their meeting held on Wednesday, July 15, 2026, has been attached herewith.
Financial Result · 15 Jul 2026, 9:17 pm
Dharti Proteins Reports Q1 FY27 Unaudited Financial Results Dharti Proteins reported unaudited standalone results for Q1 FY27 ending 30 Jun'26. Total revenue was Rs. 0.06 lakhs, a significant decline from Rs. 2.29 lakhs YoY. The company posted a net loss of Rs. 14.28 lakhs, widening from a loss of Rs. 4.60 lakhs in the same quarter last year. Total expenses rose to Rs. 14.34 lakhs from Rs. 6.89 lakhs YoY, primarily driven by higher other expenses. Basic EPS stood at Rs. (2.86) compared to Rs. (0.04) in Q1 FY26.
The outcome of meeting of Board of Directors held on Wednesday, July 15, 2026 to consider inter alia unaudited financial results for the quarter ended June 30, 2026 has been attached herewith.
Outcome · 15 Jul 2026, 9:13 pm
Devika Proteins Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh) ■ Revenue: 0.0 ■ EBITDA: -14.3 (-110.9% YoY | -118.9% QoQ) ■ EBITDA Margin (%): 0.0 ■ PAT: -14.3 (-210.4% YoY | +68.7% QoQ) ■ EPS (INR): -2.86 (-7050.0% YoY | +68.7% QoQ)